Related Experiment Video
Updated: Aug 10, 2026

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
Published on: January 31, 2014
Persistent efficacy: importance and impact of trial design
1Cyanamid International, Animal Health Division, Regional Technical Office, Louvain-la-Neuve, Belgium.
Scientific assessment of anthelmintic persistent efficacy in animals is evolving. Study design significantly impacts results, with newer methods offering more precise efficacy data for nematode control.
Area of Science:
- Veterinary Parasitology
- Pharmacology
- Animal Health
Background:
- Persistent efficacy of anthelmintics is crucial for nematode control in domestic animals.
- Current scientific assessment methods for persistent efficacy show variability in reported endpoints.
- Trial design and efficacy calculation methods significantly influence study outcomes.
Purpose of the Study:
- To compare three distinct study designs for evaluating the persistent efficacy of anthelmintics.
- To highlight the impact of trial methodology on the assessment of anthelmintic persistent efficacy.
- To identify more precise methods for determining the duration of anthelmintic activity.
Main Methods:
- Study Type 1: Animals treated, then infected at set intervals (≥7 days post-treatment); efficacy based on worm count reduction.
- Study Type 2: Animals treated, then infected daily for an extended period (≥7 days); efficacy averaged over the infection period.
- Study Type 3: Animals treated and infected as in Type 2, but slaughtered soon after the last infection (2-5 days); efficacy determined by parasite stage reduction.
Main Results:
- Study Type 1 provides efficacy data at specific time points but requires multiple control groups if multiple time points are assessed.
- Study Type 2 mimics natural infections but yields averaged efficacy, potentially masking declining protection and requiring a control group per period.
- Study Type 3 allows for more specific determination of persistent efficacy across different parasite developmental stages and requires fewer control groups.
Conclusions:
- The choice of study design critically affects the interpretation of anthelmintic persistent efficacy.
- Study Type 3 offers a more refined approach to assessing persistent efficacy, providing stage-specific data and improved efficiency.
- Further standardization of trial designs is needed to reduce variability in reported anthelmintic efficacy data.
Related Concept Videos
What is an Experiment?
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Bias in Epidemiological Studies

